FOLLOWUS
Pretreatment of Shaoyao Gancao Decoction (芍药甘草汤) alters pharmacokinetics of intravenous paclitaxel in rats
- Chinese Journal of Integrative Medicine Vol. 23, Issue 1, Pages: 70-75(2017)
- Affiliations：
1. Laboratory of Ethnopharmacology, Institute of Integrated Traditional Medicine and Western Medicine, Xiangya Hospital, Central South University,Changsha,China
2. Department of Oncology, Xiangya Hospital, Central South University,Changsha,China
3. Department of Stomatology, the Third Xiangya Hospital, Central South University,Changsha,China
4. Department of geriatrics, Xiangya Hospital, Central South University,Changsha,China
- Author bio：
- Funds：Supported by the Fundamental Research Funds for the Central Universities (Nos. 2012QNZT110 and 2012QNZT123) and the National Natural Science Foundation of China (Nos. 81202781, 81303098 and 81303074)
DOI：10.1007/s11655-016-2619-6
CLC：Published：2017，
Published Online：27 September 2016，
Scan for full text
Wang, Y., Huang, X., Zhong, Mz. et al. Pretreatment of Shaoyao Gancao Decoction (芍药甘草汤) alters pharmacokinetics of intravenous paclitaxel in rats., Chin. J. Integr. Med. 23, 70–75 (2017). https://doi.org/10.1007/s11655-016-2619-6
Yang Wang, Xi Huang, Mei-zuo Zhong, et al. Pretreatment of Shaoyao Gancao Decoction (芍药甘草汤) alters pharmacokinetics of intravenous paclitaxel in rats. [J]. Chinese Journal of Integrative Medicine 23(1):70-75(2017)
Wang, Y., Huang, X., Zhong, Mz. et al. Pretreatment of Shaoyao Gancao Decoction (芍药甘草汤) alters pharmacokinetics of intravenous paclitaxel in rats., Chin. J. Integr. Med. 23, 70–75 (2017). https://doi.org/10.1007/s11655-016-2619-6 DOI：
Yang Wang, Xi Huang, Mei-zuo Zhong, et al. Pretreatment of Shaoyao Gancao Decoction (芍药甘草汤) alters pharmacokinetics of intravenous paclitaxel in rats. [J]. Chinese Journal of Integrative Medicine 23(1):70-75(2017) DOI： 10.1007/s11655-016-2619-6.
摘要
To investigate the effect of Shaoyao Gancao Decoction (芍药甘草汤
SGD) on the pharmacokinetics of intravenously administered paclitaxel in rats. Paclitaxel was intravenously administered to rats (3 mg/kg) with or without the concomitant administration of SGD (752 mg/kg
a single day or 14 consecutive days pretreatment). The paclitaxel in the serum was quantified using a simple and rapid ultra performance liquid chromatography (UPLC) method for the pharmacokinetic study. The pharmacokinetic parameters were calculated via a non-compartment model using the computer program DAS 2.0. The pharmacokinetic parameters of paclitaxel were significantly altered in response to 14 consecutive days of pretreatment with SGD. The area under the curve (AUC0-t
from 4 820±197 to 4 205±186 ng·mL-1·-1) and AUC0-∞ (from 5 237±280 to 4 514±210 ng·mL-1·-1) significantly decreased in response to the 14-day pretreatment with SGD. The values of Vdss (L/kg) were 10.74±1.08 and 9.35±0.49
those of CL (L/kg) were 0.67±0.03 and 0.57±0.03 and the t1/2 (h) values were 11.17±0.84 and 11.32±0.93
respectively
for the 14-day SGD pretreatment and intravenous paclitaxel alone. The AUC0-t and AUC0-∞ values decreased by 13% and 14% (P<0.01)
respectively. The area under the curve decreased signifificantly (P<0.01)
and the total clearance increased by 1.2-fold (P<0.01)
after 14 consecutive days of pretreatment with SGD. A single-day pretreatment with SGD did not signifificantly affect the pharmacokinetic parameters of paclitaxel. SGD administration for 14 consecutive days increased the metabolism of paclitaxel
while a 1-day pretreatment had little effect. The results would contribute important information to the study on interaction between Chinese medicines and chemotherapy and also help to utilize SGD better in the adjunctive therapy of cancer patients.
Abstract
To investigate the effect of Shaoyao Gancao Decoction (芍药甘草汤
SGD) on the pharmacokinetics of intravenously administered paclitaxel in rats. Paclitaxel was intravenously administered to rats (3 mg/kg) with or without the concomitant administration of SGD (752 mg/kg
a single day or 14 consecutive days pretreatment). The paclitaxel in the serum was quantified using a simple and rapid ultra performance liquid chromatography (UPLC) method for the pharmacokinetic study. The pharmacokinetic parameters were calculated via a non-compartment model using the computer program DAS 2.0. The pharmacokinetic parameters of paclitaxel were significantly altered in response to 14 consecutive days of pretreatment with SGD. The area under the curve (AUC0-t
from 4 820±197 to 4 205±186 ng·mL-1·-1) and AUC0-∞ (from 5 237±280 to 4 514±210 ng·mL-1·-1) significantly decreased in response to the 14-day pretreatment with SGD. The values of Vdss (L/kg) were 10.74±1.08 and 9.35±0.49
those of CL (L/kg) were 0.67±0.03 and 0.57±0.03 and the t1/2 (h) values were 11.17±0.84 and 11.32±0.93
respectively
for the 14-day SGD pretreatment and intravenous paclitaxel alone. The AUC0-t and AUC0-∞ values decreased by 13% and 14% (P<0.01)
respectively. The area under the curve decreased signifificantly (P<0.01)
and the total clearance increased by 1.2-fold (P<0.01)
after 14 consecutive days of pretreatment with SGD. A single-day pretreatment with SGD did not signifificantly affect the pharmacokinetic parameters of paclitaxel. SGD administration for 14 consecutive days increased the metabolism of paclitaxel
while a 1-day pretreatment had little effect. The results would contribute important information to the study on interaction between Chinese medicines and chemotherapy and also help to utilize SGD better in the adjunctive therapy of cancer patients.
关键词
paclitaxelShaoyao Gancao Decoctionpharmacokineticdrug interactions
Keywords
paclitaxelShaoyao Gancao Decoctionpharmacokineticdrug interactions
references
Meijerman I, Beijnen JH, Schellens JH. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist 2006;11:742–752.
McCune JS, Hatfield AJ, Blackburn AAR, Leith PO, Livingston RB, Ellis GK. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 2004;12:454–462.
De Smet P. Clinical risk management of herb-drug interactions. Brit J Clin Pharmaco 2007;63:258–267.
Frye RF, Fitzgerald SM, Lagattuta TF, Hruska MW, Egorin MJ. Effect of St John's wort on imatinib mesylate pharmacokinetics. Clin Pharmacol Ther 2004;76:323–329.
Chiang H, Fang SH, Wen KC, Hsiu SL, Tsai SY, Hou YC, et al. Life-threatening interaction between the root extract of Pueraria lobata and methotrexate in rats. Toxicol Appl Pharm 2005;209:263–268.
Takimoto CH, Rowinsky EK. Dose-intense paclitaxel: Deja vu all over again? J Clin Oncol 2003;21:2810–2814.
Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer 2004;12:619–625.
Polomano RC, Mannes AJ, Clark US, Bennett GJ. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 2001;94:293–304.
Flatters SJ, Bennett GJ. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 2006;122:245–257.
Gan PP, Huang X, Sun M, Wang Y, Zhong MZ. Determination of six major compounds in Shaoyao-Gancao-Tang and its single herb decoctions. Asian J Chem 2011;23:1515–1519.
Wu TH, Chiu TY, Tsai JS, Chen CY, Chen LC, Yang LL. Effectiveness of Taiwanese traditional herbal diet for pain management in terminal cancer patients. Asia Pac J Clin Nutr 2008;17:17–22.
Yoshida T, Sawa T, Ishiguro T, Horiba A, Minatoguchi S, Fujiwara H. The efficacy of prophylactic Shakuyaku-Kanzoto for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer. Support Care Cancer 2009;17:315–320.
Fujii K, Okamoto S, Saitoh K, Sasaki N, Takano M, Tanaka S, et al. The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma. Cancer chemotherapy 2004;31:1537–1540.
Yamamoto K, Hoshiai H, Noda K. Effects of shakuyakukanzo- to on muscle pain from combination chemotherapy with paclitaxel and carboplatin. Gynecol Oncol 2001;81:333–334.
Hidaka T, Shima T, Nagira K, Ieki M, Nakamura T, Aono Y, et al. Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice. Eur J Pain 2009;13:22–27.
Endo M, Oikawa T, Nunome S, Yamada H, Hanawa T. Pharmacological analysis for the optimal combination ratio of Shakuyaku and Kanzo in Shakuyakukanzoto. J Trad Med 2007;24:39–42.
Kim SC, Yu J, Lee JW, Park ES, Chi SC. Sensitive HPLC method for quantitation of paclitaxel (Genexol (R)) in biological samples with application to preclinical pharmacokinetics and biodistribution. J Pharmaceut Biomed 2005;39:170–176.
Harris JW, Rahman A, Kim BR, Guengerich FP, Collins JM. Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res 1994;54:4026–4035.
Gustafson DL, Long ME, Bradshaw EL, Merz AL, Kerzic PJ. P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing. Cancer Chemoth Pharm 2005;56:248–254
Foster BC, Vandenhoek S, Li KY, Tang R, Budzinski JW, Krantis A. Effect of several Chinese natural health products of human cytochrome P450 metabolism. J Pharm Sci 2002;5:185–189.
Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003;290:1500–1504.
Tang JC, Zhang JN, Wu YT, Li ZX. Effect of the water extract and ethanol extract from traditional Chinese medicines Angelica sinensis (Oliv.) Diels, Ligusticum chuanxiong Hort. and Rheum palmatum L. on rat liver cytochrome P450 activity. Phytother Res 2006;20:1046–1051.
Mu Y, Zhang JN, Zhang SM, Zhou HH, Toma D, Ren SS, et al. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther 2006;316:1369–1377.
Tang JC, Song XH, Zhu M, Zhang JN. Study on the pharmacokinetics drug-drug interaction potential of Glycyrrhiza uralensis, a traditional Chinese medicine, with lidocaine in rats. Phytother Res 2009;23:603–607.
Gan PP, Zhong MZ, Huang X, Sun M, Wang Y, Xiao YY, et al. Pharmacokinetic comparisons of albiflorin and paeoniflorin after oral administration of Shaoyao-Gancao-Tang and single herb Paeony decoction to rats. Planta Med 2012;78:237–243.
Wu BL, Liu P, Gao Y, Wang YG. Effect of water extract from traditional Chinese medicines Rehmannia glutinosa, Scrophularia ningpoensis, Asparagus cochinchinensis and Ophiopogon japonicas on contents of CYP450 and activities of CYP3A, CYP2E1 and CYP1A2 in rat. China J Chin Mater Med (Chin) 2011;36:2710–2714.
Pal D, Mitra AK. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci 2006;78:2131–2145.
Yang GY, Li X, Li XL, Wang L, Li J, Song X, et al. Traditional Chinese medicine in cancer care: a review of case series published in the Chinese literature. Evid Based Complement Alternat Med 2012;2012:751046.
Lin HS, Liu J, Zhang Y. Developments in cancer prevention and treatment using traditional Chinese medicine. Front Med 2011;5:127–133.
0
Views
0
Downloads
1
CSCD
- Meta-XMLDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
- Tel：010-62886827, 62877592 Fax：010-62874291
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
